Items where authors include "King, H"
Up a levelArticle
Mebrahtu, TF orcid.org/0000-0003-4821-2304, Skyrme, S, Randell, R et al. (7 more authors) (2021) Effects of computerised clinical decision support systems (CDSS) on nursing and allied health professional performance and patient outcomes: a systematic review of experimental and observational studies. BMJ Open, 11 (12). e053886. ISSN 2044-6055
Mebrahtu, TF orcid.org/0000-0003-4821-2304, Bloor, K, Ledward, A et al. (7 more authors) (2021) Effects of computerised clinical decision support systems (CDSS) on nursing and allied health professional performance and patient outcomes. Cochrane Library (3). CD014699. ISSN 1465-1858
Cummings, M, King, H, Hurst, J orcid.org/0000-0002-5216-7000 et al. (11 more authors) (2020) Decreasing formalin concentration improves quality of DNA extracted from formalin-fixed paraffin-embedded tissue specimens without compromising tissue morphology or immunohistochemical staining. Journal of Clinical Pathology, 73 (8). pp. 514-518. ISSN 0021-9746
Boissinot, M orcid.org/0000-0002-5241-2520, King, H, Adams, M et al. (18 more authors) (2020) Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300. Oncogene. ISSN 0950-9232
Droop, A orcid.org/0000-0001-7695-7480, Bruns, A orcid.org/0000-0002-6970-4036, Tanner, G et al. (12 more authors) (2018) How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: A case study using paired primary and recurrent glioblastoma. International Journal of Cancer, 142 (8). pp. 1620-1626. ISSN 0020-7136
Yahyanejad, S, King, H, Iglesias, VS et al. (12 more authors) (2016) NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma. Oncotarget, 7 (27). pp. 41251-41264. ISSN 1949-2553
Proceedings Paper
Boissinot, M, King, H, Adams, M et al. (7 more authors) (2016) Ectopic expression of microRNA-1300 in adult and paediatric glioma cells induces cytokinesis failure and apoptosis via ECT2. In: Neuro-Oncology. 12th Meeting of the European Association of Neuro-Oncology, 12-16 Oct 2016, Mannheim/Heidelberg, Germany. Oxford University Press , iv18-iv18.